210 related articles for article (PubMed ID: 22556267)
1. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer.
O'Donnell KA; Keng VW; York B; Reineke EL; Seo D; Fan D; Silverstein KA; Schrum CT; Xie WR; Mularoni L; Wheelan SJ; Torbenson MS; O'Malley BW; Largaespada DA; Boeke JD
Proc Natl Acad Sci U S A; 2012 May; 109(21):E1377-86. PubMed ID: 22556267
[TBL] [Abstract][Full Text] [Related]
2. SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
Suresh S; Durakoglugil D; Zhou X; Zhu B; Comerford SA; Xing C; Xie XJ; York B; O'Donnell KA
PLoS Genet; 2017 Mar; 13(3):e1006650. PubMed ID: 28273073
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
4.
Tschida BR; Temiz NA; Kuka TP; Lee LA; Riordan JD; Tierrablanca CA; Hullsiek R; Wagner S; Hudson WA; Linden MA; Amin K; Beckmann PJ; Heuer RA; Sarver AL; Yang JD; Roberts LR; Nadeau JH; Dupuy AJ; Keng VW; Largaespada DA
Cancer Res; 2017 Dec; 77(23):6576-6588. PubMed ID: 28993411
[TBL] [Abstract][Full Text] [Related]
5. Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma.
Kodama T; Bard-Chapeau EA; Newberg JY; Kodama M; Rangel R; Yoshihara K; Ward JM; Jenkins NA; Copeland NG
Gastroenterology; 2016 Aug; 151(2):324-337.e12. PubMed ID: 27178121
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
7. Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression.
Lo LH; Lam CY; To JC; Chiu CH; Keng VW
Biochem Biophys Res Commun; 2021 Feb; 541():70-77. PubMed ID: 33482578
[TBL] [Abstract][Full Text] [Related]
8. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.
Keng VW; Villanueva A; Chiang DY; Dupuy AJ; Ryan BJ; Matise I; Silverstein KA; Sarver A; Starr TK; Akagi K; Tessarollo L; Collier LS; Powers S; Lowe SW; Jenkins NA; Copeland NG; Llovet JM; Largaespada DA
Nat Biotechnol; 2009 Mar; 27(3):264-74. PubMed ID: 19234449
[TBL] [Abstract][Full Text] [Related]
9. Liver-Specific Delivery of Sleeping Beauty Transposon System by Hydrodynamic Injection for Cancer Gene Validation.
Chiu AP; Keng VW
Methods Mol Biol; 2019; 1907():185-196. PubMed ID: 30543001
[TBL] [Abstract][Full Text] [Related]
10. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
[TBL] [Abstract][Full Text] [Related]
11. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
[TBL] [Abstract][Full Text] [Related]
12. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
[TBL] [Abstract][Full Text] [Related]
13. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen.
Rahrmann EP; Collier LS; Knutson TP; Doyal ME; Kuslak SL; Green LE; Malinowski RL; Roethe L; Akagi K; Waknitz M; Huang W; Largaespada DA; Marker PC
Cancer Res; 2009 May; 69(10):4388-97. PubMed ID: 19401450
[TBL] [Abstract][Full Text] [Related]
14. Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.
Kodama T; Newberg JY; Kodama M; Rangel R; Yoshihara K; Tien JC; Parsons PH; Wu H; Finegold MJ; Copeland NG; Jenkins NA
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3384-93. PubMed ID: 27247392
[TBL] [Abstract][Full Text] [Related]
15. Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.
Carlson CM; Frandsen JL; Kirchhof N; McIvor RS; Largaespada DA
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17059-64. PubMed ID: 16286660
[TBL] [Abstract][Full Text] [Related]
16. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.
Jang KY; Noh SJ; Lehwald N; Tao GZ; Bellovin DI; Park HS; Moon WS; Felsher DW; Sylvester KG
PLoS One; 2012; 7(9):e45119. PubMed ID: 23024800
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
19. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
20. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.
Sargent LM; Zhou X; Keck CL; Sanderson ND; Zimonjic DB; Popescu NC; Thorgeirsson SS
Am J Pathol; 1999 Apr; 154(4):1047-55. PubMed ID: 10233843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
